Yongshui Fu Selected Research

Yongshui Fu Research Topics

Disease

12	Infections 11/2023 - 03/2009
5	COVID-19 08/2022 - 01/2021
4	Thrombocytopenia (Thrombopenia) 01/2023 - 12/2013
4	Neonatal Alloimmune Thrombocytopenia 01/2022 - 12/2013
4	Platelet Glycoprotein IV Deficiency 01/2022 - 12/2013
2	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 11/2023
2	Necrosis 11/2023 - 12/2021
2	Viremia 11/2023 - 01/2020
2	Transfusion-Related Acute Lung Injury 01/2023 - 06/2011
2	Hydrops Fetalis (Fetal Edema) 07/2022 - 10/2020
2	Hemorrhage 01/2022 - 12/2013
2	Persistent Infection 01/2022 - 10/2019
2	Hepatitis B 03/2020 - 01/2020
1	Toxoplasmosis 01/2024
1	Brucellosis (Malta Fever) 01/2024
1	Hepatitis C 12/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2023
1	Common Cold 08/2022
1	Human Influenza (Influenza) 08/2022
1	Wounds and Injuries (Trauma) 05/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2022
1	Fetal Death 11/2021
1	Zika Virus Infection 01/2020
1	Hepatitis 01/2020
1	Inflammation (Inflammations) 01/2020
1	Hepatitis E 01/2019
1	Hemophilia A (Haemophilia) 07/2018
1	Coinfection 07/2018
1	Neonatal hemochromatosis 12/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2016
1	Neoplasms (Cancer) 01/2016
1	Stomach Neoplasms (Stomach Cancer) 10/2014
1	Transfusion Reaction 12/2013
1	Disease Progression 05/2013
1	Blood-Borne Infections 08/2012
1	Syphilis 08/2012
1	Neutropenia 06/2011
1	Teratoma (Teratoid Tumor) 01/2010

Drug/Important Bio-Agent (IBA)

8	AntibodiesIBA 01/2023 - 06/2011
7	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2023 - 08/2012
6	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 03/2009
4	AntigensIBA 01/2023 - 06/2011
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
3	VaccinesIBA 12/2023 - 12/2017
3	RNA (Ribonucleic Acid)IBA 11/2023 - 07/2018
3	Peptides (Polypeptides)IBA 11/2023 - 01/2013
3	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2013
3	Nucleic AcidsIBA 08/2022 - 01/2021
3	EnzymesIBA 12/2021 - 08/2012
3	ImmunosorbentsIBA 12/2021 - 08/2012
2	CytokinesIBA 01/2024 - 12/2021
2	Interleukin-10 (Interleukin 10)IBA 01/2024 - 01/2022
2	Hepatitis B Core AntigensIBA 11/2023 - 11/2023
2	Immunoglobulin G (IgG)IBA 08/2022 - 01/2021
2	Monoclonal AntibodiesIBA 07/2020 - 01/2013
2	HLA Antigens (Human Leukocyte Antigens)IBA 10/2019 - 01/2015
1	CarbonIBA 01/2024
1	Interleukin-6 (Interleukin 6)IBA 01/2024
1	pgRNAIBA 11/2023
1	Collagen Type III (Type III Collagen)IBA 11/2023
1	Laminin (Merosin)IBA 11/2023
1	Collagen Type IV (Type IV Collagen)IBA 11/2023
1	Hyaluronic Acid (Hyaluronan)IBA 11/2023
1	Inactivated VaccinesIBA 08/2022
1	Subunit VaccinesIBA 08/2022
1	RHO(D) antibody (anti-D)IBA 05/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	IsoantibodiesIBA 01/2022
1	interleukin-21 (interleukin 21)IBA 01/2022
1	Integrin beta3 (GPIIIa)IBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 12/2021
1	Neutralizing AntibodiesIBA 11/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 11/2021
1	PhosphoproteinsIBA 01/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Viral RNAIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Surface Antigens (Surface Antigen)IBA 01/2020
1	LigandsIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 12/2017
1	hepatitis B hyperimmune globulinIBA 12/2017
1	HLA-B Antigens (HLA-B)IBA 01/2015
1	sphingosine kinaseIBA 10/2014
1	NucleotidesIBA 12/2013
1	EpitopesIBA 01/2013
1	stage-specific embryonic antigen-4IBA 01/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2010
1	Alkaline PhosphataseIBA 01/2010

Therapy/Procedure

2	Platelet Transfusion (Blood Platelet Transfusions) 01/2022 - 12/2013
2	Blood Transfusion (Blood Transfusions) 07/2018 - 08/2012
2	Therapeutics 05/2013 - 01/2013
1	Nanospheres 01/2024
1	Transplantation 01/2016